Task: Answer the multiple-choice question.
Question: Which drug exhibits a -0.626\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a) Cc1cc2ccccn2c1C(=O)c1nc(NCc2ccccc2)ncc1Cl
b) CCCCN1C(=O)/C(=C/C=C2/C=Cc3ccccc3N2CC)SC1=S
c) COc1ccc(C(=O)n2nc(-c3ccco3)nc2N)cc1
d) CCSc1nnc2ccc(-c3ccc(OC)c(OC)c3)nn12
Answer: b. CCCCN1C(=O)/C(=C/C=C2/C=Cc3ccccc3N2CC)SC1=S
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCN1C(=O)/C(=C/C=C2/C=Cc3ccccc3N2CC)SC1=S
CCCCN1C(=O)/C(=C/C=C2/C=Cc3ccccc3N2CC)SC1=S
(5Z)-3-butyl-5-[(2Z)-2-(1-ethylquinolin-2-ylidene)ethylidene]-2-sulfanylidene-1,3-thiazolidin-4-one